Publicaciones en colaboración con investigadores/as de University of Pittsburgh School of Medicine (29)

2022

  1. Blueberry juice augments exercise-induced neuroprotection in a Parkinson's disease model through modulation of GDNF levels

    IBRO Neuroscience Reports, Vol. 12, pp. 217-227

  2. Environmental enrichment improves traumatic brain injury-induced behavioral phenotype and associated neurodegenerative process

    Experimental Neurology, Vol. 357

2019

  1. Phenothiazine normalizes the NADH/NAD + ratio, maintains mitochondrial integrity and protects the nigrostriatal dopamine system in a chronic rotenone model of Parkinson's disease

    Redox Biology, Vol. 24

2018

  1. Mitochondrial Complex i Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease

    Antioxidants and Redox Signaling, Vol. 28, Núm. 1, pp. 44-61

  2. Resveratrol and pinostilbene confer neuroprotection against aging-related deficits through an ERK1/2-dependent mechanism

    Journal of Nutritional Biochemistry, Vol. 54, pp. 77-86

2017

  1. ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice

    Journal of Alzheimer's Disease, Vol. 56, Núm. 3, pp. 1075-1085

  2. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Nature Genetics, Vol. 49, Núm. 5, pp. 680-691

  3. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production

    Cellular and Molecular Life Sciences, Vol. 74, Núm. 15, pp. 2851-2874

2015

  1. Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats

    Neurobiology of Aging, Vol. 36, Núm. 1, pp. 505-518

  2. ShRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model

    Journal of Clinical Investigation, Vol. 125, Núm. 7, pp. 2721-2735

2014

  1. A rapid and sensitive automated image-based approach for in vitro and in vivo characterization of cell morphology and quantification of cell number and neurite architecture

    Current Protocols in Cytometry

  2. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508

  3. Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease

    Neurobiology of Aging, Vol. 35, Núm. 5, pp. 1162-1176

2013

  1. Automated imaging system for fast quantitation of neurons, cell morphology and neurite morphometry in vivo and in vitro

    Neurobiology of Disease, Vol. 54, pp. 158-168

  2. Central role for MCP-1/CCL2 in injury-induced inflammation revealed by in vitro, in silico, and clinical studies

    PLoS ONE, Vol. 8, Núm. 12

  3. Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment

    Experimental Neurology, Vol. 240, Núm. 1, pp. 44-56

  4. Synuclein-Mitochondrial Interactions in Substantia Nigra Dopamine Neurons

    Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012 (Elsevier Inc.), pp. 126-127

2011

  1. Single-cell redox imaging demonstrates a distinctive response of dopaminergic neurons to oxidative insults

    Antioxidants and Redox Signaling, Vol. 15, Núm. 4, pp. 855-871

2010

  1. Melatonin treatment potentiates neurodegeneration in a rat rotenone parkinson's disease model

    Journal of Neuroscience Research, Vol. 88, Núm. 2, pp. 420-427

2009

  1. A highly reproducible rotenone model of Parkinson's disease

    Neurobiology of Disease, Vol. 34, Núm. 2, pp. 279-290